Position in GH
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$16,353
+$14,598 QoQ
Shares Held
109
+473.7% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#510
of 594 holders
Holding Since
Dec 2022
3 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in GH Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026J.Safra Asset Management Corp holds $2,979,027 across 13 Diagnostics & Research names. GH ranks #10 (0.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | DGX |
Quest Diagnostics Inc
|
4,621 | $979,420 | |
| 2 | LH |
Labcorp Holdings Inc.
|
2,421 | $677,880 | |
| 3 | IQV |
Iqvia Holdings Inc.
|
3,292 | $636,080 | |
| 4 | DHR |
Danaher Corp /De/
|
1,600 | $304,768 | |
| 5 | TMO |
Thermo Fisher Scientific Inc.
|
516 | $258,701 | |
| 6 | IDXX |
Idexx Laboratories Inc /De
|
48 | $25,269 | |
| 7 | A |
Agilent Technologies, Inc.
|
159 | $21,119 | |
| 8 | NTRA |
Natera, Inc.
|
67 | $18,187 |
All Filings in GH
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $16,353 | 109 | Shares | Sole | 2026-08-06 | |
| 2026-03-31 | $1,755 | 19 | Shares | Sole | 2026-05-04 | |
| 2022-12-31 | $680 | 25 | Shares | Sole | 2023-02-10 | |
| No filing history on record for this holder in this stock. | ||||||